P-181 Exploratory randomized phase II trial for optimizing treatment dosage and duration of adjuvant S-1 plus oxaliplatin in patients with stage III colon cancer (SOAP trial)

Annals of Oncology ◽

10.1016/j.annonc.2021.05.236 ◽

2021 ◽

Vol 32 ◽

pp. S161-S162

Author(s):

Y. Suwa ◽

J. Watanabe ◽

H. Suwa ◽

M. Ozawa ◽

M. Momiyama ◽

...

Keyword(s):

Colon Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Stage Iii ◽

Stage Iii Colon Cancer ◽

Randomized Phase Ii ◽

Treatment Dosage

Download Full-text

Interim analysis of a phase II trial evaluating the safety and efficacy of capecitabine plus oxaliplatin (XELOX) as adjuvant therapy in Japanese patients with operated stage III colon cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-017-3419-1 ◽

2017 ◽

Vol 80 (4) ◽

pp. 777-785 ◽

Cited By ~ 4

Author(s):

Katsuki Danno ◽

◽

Taishi Hata ◽

Koki Tamai ◽

Yujiro Fujie ◽

...

Keyword(s):

Colon Cancer ◽

Adjuvant Therapy ◽

Phase Ii ◽

Interim Analysis ◽

Phase Ii Trial ◽

Japanese Patients ◽

Stage Iii ◽

Safety And Efficacy ◽

Stage Iii Colon Cancer

Download Full-text

RANDOMIZED PHASE II TRIAL OF CARBOPLATIN-PACLITAXEL COMPARED TO CARBOPLATIN-PACLITAXEL-TRASTUZUMAB IN ADVANCED (STAGE III-IV) OR RECURRENT UTERINE SEROUS CARCINOMA: RESULTS OF INTERIM ANALYSIS (NCT01367002)

10.26226/morressier.5770e29bd462b80290b4bae3 ◽

2016 ◽

Author(s):

Alessandro D Santin

Keyword(s):

Phase Ii ◽

Interim Analysis ◽

Phase Ii Trial ◽

Stage Iii ◽

Serous Carcinoma ◽

Advanced Stage ◽

Randomized Phase Ii ◽

Uterine Serous Carcinoma

Download Full-text

North Japan multicenter phase II study of FOLFOX as adjuvant chemotherapy for stage III colon cancer (NORTH/HGCSG1003): Analysis of tumor location

Annals of Oncology ◽

10.1093/annonc/mdx393.017 ◽

2017 ◽

Vol 28 ◽

pp. v165

Author(s):

A. Ishiguro ◽

S. Yuki ◽

Y. Kawamoto ◽

H. Nakatsumi ◽

N. Takahashi ◽

...

Keyword(s):

Colon Cancer ◽

Adjuvant Chemotherapy ◽

Phase Ii ◽

Phase Ii Study ◽

Tumor Location ◽

Stage Iii ◽

Stage Iii Colon Cancer ◽

Multicenter Phase

Download Full-text

Sixteen years follow-up results of a randomized phase II trial of neoadjuvant fluorouracil, doxorubicin, and cyclophosphamide (FAC) compared with cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in stage III breast cancer: GOCS experience

Breast Cancer Research and Treatment ◽

10.1007/s10549-013-2806-5 ◽

2013 ◽

Vol 143 (2) ◽

pp. 313-323 ◽

Cited By ~ 6

Author(s):

José Pablo Leone ◽

Julieta Leone ◽

Carlos Teodoro Vallejo ◽

Juan Eduardo Pérez ◽

Alberto Omar Romero ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Stage Iii ◽

Randomized Phase Ii ◽

Stage Iii Breast Cancer

Download Full-text

P382 A randomized phase II trial of sequential gemcitabine plusvinorelbine followed by gemcitabine plus Ifosfamide versus gemcitabine plus cisplatin in the treatment of chemonaïve patients with stage III and IV non-small cell lung cancer (NSCLC)

Lung Cancer ◽

10.1016/s0169-5002(05)81075-x ◽

2005 ◽

Vol 49 ◽

pp. S271

Author(s):

G. Teodorescu ◽

T. Ciuleanu ◽

A. Grigorescu ◽

E. Firoiu ◽

D. Ruta Muresan

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Stage Iii ◽

Small Cell Lung ◽

Randomized Phase Ii

Download Full-text

Randomized Phase II Trial of Carboplatin–Paclitaxel Compared with Carboplatin–Paclitaxel–Trastuzumab in Advanced (Stage III–IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-20-0953 ◽

2020 ◽

Vol 26 (15) ◽

pp. 3928-3935 ◽

Cited By ~ 3

Author(s):

Amanda N. Fader ◽

Dana M. Roque ◽

Eric Siegel ◽

Natalia Buza ◽

Pei Hui ◽

...

Keyword(s):

Overall Survival ◽

Survival Analysis ◽

Phase Ii ◽

Phase Ii Trial ◽

Stage Iii ◽

Advanced Stage ◽

Randomized Phase Ii ◽

Overall Survival Analysis

Download Full-text

MA05.07 Dose Escalated Chemo-RT to 84 Gy in Stage III NSCLC Appears Excessively Toxic: Results from a Randomized Phase II Trial

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2018.08.354 ◽

2018 ◽

Vol 13 (10) ◽

pp. S373

Author(s):

J. Nyman ◽

S. Bergström ◽

H. Björkestrand ◽

A. Svärd ◽

S. Ekman ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Trial ◽

Stage Iii ◽

Randomized Phase Ii ◽

Stage Iii Nsclc

Download Full-text

163P Safety analysis of FOLFOX as adjuvant chemotherapy for stage III colon cancer in phase II study (NORTH/HGCSG1003) - an analysis of surgeons vs oncologists

Annals of Oncology ◽

10.1093/annonc/mdv523.24 ◽

2015 ◽

Vol 26 ◽

pp. ix42

Author(s):

A. Ishiguro ◽

S. Yuki ◽

Y. Kawamoto ◽

F. Nakamura ◽

N. Takahashi ◽

...

Keyword(s):

Colon Cancer ◽

Adjuvant Chemotherapy ◽

Phase Ii ◽

Phase Ii Study ◽

Safety Analysis ◽

Stage Iii ◽

Stage Iii Colon Cancer

Download Full-text

NORTH/HGCSG1003: A phase II study evaluating the safety and efficacy of FOLFOX as adjuvant chemotherapy for patients with stage III colon cancer: Comparison with medical oncologists and surgeons

Annals of Oncology ◽

10.1093/annonc/mdy151.222 ◽

2018 ◽

Vol 29 ◽

pp. v62

Author(s):

S. Yuki ◽

Y. Komatsu ◽

Y. Kawamoto ◽

H. Nakatsumi ◽

N. Takahashi ◽

...

Keyword(s):

Colon Cancer ◽

Adjuvant Chemotherapy ◽

Phase Ii ◽

Phase Ii Study ◽

Stage Iii ◽

Safety And Efficacy ◽

Stage Iii Colon Cancer ◽

Medical Oncologists

Download Full-text

A Phase II Clinical Study of mFOLFOX6 /XELOX as Adjuvant Chemotherapy after Curative Resection of Stage III Colon Cancer: The FACOS Study

Annals of Cancer Research and Therapy ◽

10.4993/acrt.24.17 ◽

2016 ◽

Vol 24 (1) ◽

pp. 17-22 ◽

Cited By ~ 1

Author(s):

Keiichiro Ishibashi ◽

Kensuke Kumamoto ◽

Keiji Koda ◽

Hiroyuki Kato ◽

Genichi Nishimura ◽

...

Keyword(s):

Colon Cancer ◽

Clinical Study ◽

Adjuvant Chemotherapy ◽

Phase Ii ◽

Curative Resection ◽

Stage Iii ◽

Stage Iii Colon Cancer ◽

Phase Ii Clinical Study

Download Full-text